BIOMERICA INC. - COMMON STOCK

Biomerica provides update on inFoods® IBS expansion

15 Apr 2024 06:47:00 By Nasdaq GlobeNewswire

Biomerica Reports Third Quarter 2024 Financial Results

12 Apr 2024 18:23:53 By Nasdaq GlobeNewswire

Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference

28 Mar 2024 07:19:00 By Nasdaq GlobeNewswire

Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board

21 Feb 2024 07:19:00 By Nasdaq GlobeNewswire

Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica

23 Jan 2024 07:19:00 By Nasdaq GlobeNewswire

Biomerica Reports Second Quarter 2024 Financial Results

16 Jan 2024 07:19:00 By Nasdaq GlobeNewswire

Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population

18 Dec 2023 06:47:00 By Nasdaq GlobeNewswire

Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16

10 Nov 2023 07:19:00 By Nasdaq GlobeNewswire

Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups

08 Nov 2023 07:19:00 By Nasdaq GlobeNewswire

REPEAT - Biomerica Reports First Quarter 2024 Financial Results

13 Oct 2023 12:10:28 By Nasdaq GlobeNewswire

Biomerica Reports First Quarter 2024 Financial Results

13 Oct 2023 05:39:00 By Nasdaq GlobeNewswire

Dubai Government Grants Insurance Reimbursement for Biomerica’s EZ Detect™ Colorectal Disease Screening Test

26 Sep 2023 07:19:00 By Nasdaq GlobeNewswire

Diagnostics Industry Leader Jack Kenny Joins Biomerica’s Board of Directors

28 Aug 2023 07:19:00 By Nasdaq GlobeNewswire

Biomerica Reports Fiscal 2023 Year End Results

25 Aug 2023 16:00:00 By Nasdaq GlobeNewswire

CVS Health to Begin Nationwide In-Store Sales of Biomerica’s EZ Detect™ Colorectal Disease Screening Test

03 Aug 2023 07:19:00 By Nasdaq GlobeNewswire

Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients

21 Jun 2023 07:19:00 By Nasdaq GlobeNewswire

inFoods® IBS Test Now Validated for Use with Simple Finger Stick Whole Blood Collection Technology

18 May 2023 07:19:00 By Nasdaq GlobeNewswire

Biomerica’s inFoods® IBS test is now available at Gastro Health, providing a revolutionary new treatment for patients suffering from Irritable Bowel Syndrome (IBS).

17 Apr 2023 06:47:00 By Nasdaq GlobeNewswire

Biomerica Reports Q3 Fiscal 2023 Results

14 Apr 2023 15:48:29 By Nasdaq GlobeNewswire

Biomerica announces the Launch of InFoods IBS as a Laboratory Developed Test (LDT); First patient samples have been processed

08 Mar 2023 07:19:00 By Nasdaq GlobeNewswire